ILJIN SNT Reduces Stake in Aurinia Pharmaceuticals Below 5% Threshold

ILJIN SNT Co., Ltd. and associated reporting persons, including Chin Kyu Huh, ILJIN Steel, and ILJIN GLS, filed Amendment No. 17 to their Schedule 13D for Aurinia Pharmaceuticals Inc. (AUPH) on August 26, 2026. The filing reports a series of open-market sales of common shares occurring between June and August 2026. Specifically, ILJIN SNT sold 423,904 shares, ILJIN Steel sold 200,000 shares, and Seoung Eun Huh sold 16,391 shares. Following a final transaction on August 20, 2026, the reporting persons' aggregate beneficial ownership fell below the 5% threshold. ILJIN SNT now directly holds 4,987,629 shares, representing approximately 3.7% of the outstanding common shares. Chin Kyu Huh, who maintains voting and investment control over several of the entities, reports a combined beneficial ownership of 5,911,237 shares (4.4%). Because their collective ownership has dropped below 5%, the reporting persons stated they will no longer be required to file reports under Section 13(d) for this security.